Back
ESC2025 Premium Access

Beyond stability: unveiling the prognostic and therapeutic role of serum transthyretin in amyloid cardiomyopathy

Session: Prognostication and treatment of transthyretin cardiac amyloidosis
Topic: Infiltrative Myocardial Disease
Speaker: Doctor J. Costantino (Rome, IT)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Jacopo Costantino

Sapienza University of Rome, Rome (Italy)
1 presentation
1 follower

7 more presentations in this session

Cardiac resynchronization therapy, remodeling and outcome in patients with amyloid transthyretin cardiomyopathy

Speaker: Doctor A. Aimo (Pisa, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

When to stop? Real-world decision pathways for transthyretin stabilizer discontinuation in cardiac amyloidosis

Speaker: Doctor K. Knoll (Munich, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Impaired right ventricular free wall strain predicts mortality in patients with stabilizer-treated transthyretin amyloid cardiomyopathy.

Speaker: Doctor S. Schwarting (Munich, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Distribution and prognostic impact of left and right systolic and diastolic functions in wild-type transthyretin amyloid cardiomyopathy

Speaker: Doctor A. Mejren (Aarhus, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Identifying predictors and cutoff values for pacemaker implantation in ATTR patients

Speaker: Doctor S. Istratoaie (Cluj Napoca, RO)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Prognostication and treatment of transthyretin cardiac amyloidosis

Speakers: Doctor J. Costantino, Doctor A. Aimo, Doctor K. Knoll, Doctor S. Schwarting, Doctor A. Mejren...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources